GE Healthcare has announced plans to allocate $1 billion over five years to expand its diagnostic and imaging capabilities in oncology as well as to improve its manufacturing technologies. This will include new spending on biomarkers. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
